Trial ID or NCT#
The investigators are testing treatment with low-dose naltrexone (LDN) for symptom relief of complex regional pain syndrome (CRPS). Study participants will be randomly assigned to receive either LDN or placebo for a period of several weeks. During this period participants will be asked to come to several visits, which will include sensory testing, physical assessments, and questionnaires.
Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
Contact us to find out if this trial is right for you.